Contrasting Presidio Property Trust (NASDAQ:SQFTW) and Essential Properties Realty Trust (NYSE:EPRT)

Essential Properties Realty Trust (NYSE:EPRT) and Presidio Property Trust (NASDAQ:SQFTW) are both real estate companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Profitability

This table compares Essential Properties Realty Trust and Presidio Property Trust’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Essential Properties Realty Trust	43.51%	6.34%	3.81%
Presidio Property Trust	N/A	N/A	N/A

Earnings & Valuation

This table compares Essential Properties Realty Trust and Presidio Property Trust”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essential Properties Realty Trust	$561.22 million	11.79	$253.01 million	$1.29	23.72
Presidio Property Trust	$16.46 million	N/A	N/A	N/A	N/A

Essential Properties Realty Trust has higher revenue and earnings than Presidio Property Trust.

Analyst Ratings

This is a breakdown of current ratings and price targets for Essential Properties Realty Trust and Presidio Property Trust, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essential Properties Realty Trust	0	0	11	1	3.08
Presidio Property Trust	0	0	0	0	0.00

Essential Properties Realty Trust presently has a consensus price target of $36.20, suggesting a potential upside of 18.33%. Given Essential Properties Realty Trust’s stronger consensus rating and higher possible upside, analysts clearly believe Essential Properties Realty Trust is more favorable than Presidio Property Trust.

Insider and Institutional Ownership

97.0% of Essential Properties Realty Trust shares are owned by institutional investors. 0.8% of Essential Properties Realty Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Essential Properties Realty Trust beats Presidio Property Trust on 10 of the 10 factors compared between the two stocks.

About Essential Properties Realty Trust

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

About Presidio Property Trust

Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.